Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: rosiglitazone maleate

See Plans and Pricing

« Back to Dashboard

rosiglitazone maleate Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Dr Reddys Labs Inc rosiglitazone maleate 076748 8MG TABLET; ORAL
Hikma Pharms rosiglitazone maleate 078658 8MG TABLET; ORAL
Watson Labs rosiglitazone maleate 078023 4MG TABLET; ORAL
Sandoz rosiglitazone maleate 078674 8MG TABLET; ORAL
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.